EAU 2013 - Programme Book - YouMed

Conclusion
S.F.M. Thüroff, Munich (DE)
Aims and objectives
Today, earlier diagnosis of localized prostate cancer has caused as a trend to more low risk, early stage as
an elevated number of prostate cancers at first diagnosis. While surgery and radiation therapy are „golden
standard“ therapies choosen by the urologist, modern less invasive technologies are greeted with ever
more enthusiasm by patients. This simply creates a dilemma. In this course about minimal invasive PCa
therapy status quo and long term results, indispensible for correct oncological evidence based evaluation are
reported, as well as presentation and discussion of pilotstudies in specific indications, not yet subject to local
minimal invasive treatment today.
Brachy-, Cryo- and HIFU-therapy as representatives for low invasive minimal invasive technologies are not
„experimental“ but „investational“, clinically available therapies for urologists and derserving attention.
Urologists have to be informed about their potential, side effects and limitations to give „updated“
informations to their patients.
This course will demonstrate these technologies, their results and complications on the other side highlight,
why in selected cases „hightech prostate cancer therapy“ might be equal or individually superior to
conventional therapeutic approaches. Discussion about „focal therapy“, „clinical cases“ and current guideline
status quo -as exchange of opinions with the participants-will close this 3 hour course.
Registration fee excluding VAT
EAU members € 47
Non-EAU members € 69
Residents (members/non-members) € 21
EAU Milan 2013
359
ESU Courses